Matches in Wikidata for { <http://www.wikidata.org/entity/Q64612775> ?p ?o ?g. }
Showing items 1 to 38 of
38
with 100 items per page.
- Q64612775 description "clinical trial" @default.
- Q64612775 description "ensayu clínicu" @default.
- Q64612775 description "klinisch onderzoek" @default.
- Q64612775 description "клінічне випробування" @default.
- Q64612775 name "Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer" @default.
- Q64612775 type Item @default.
- Q64612775 label "Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer" @default.
- Q64612775 prefLabel "Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer" @default.
- Q64612775 P1132 Q64612775-882CBC8E-62B8-40F0-BC23-BC205ED79F1D @default.
- Q64612775 P1476 Q64612775-96721F85-2C76-48E6-A3D9-624901713DD5 @default.
- Q64612775 P17 Q64612775-AC2FBF11-3A18-4BC4-BAAE-C843CAEF5F7B @default.
- Q64612775 P2899 Q64612775-7179B161-FC35-4798-AB91-415B97A1B37D @default.
- Q64612775 P3098 Q64612775-A893BFA2-52ED-4D07-A040-E0D579F01A1E @default.
- Q64612775 P31 Q64612775-2E85A51F-6DCA-46AD-82B1-ECFB27433CC7 @default.
- Q64612775 P4844 Q64612775-909E1724-959F-4357-B3D0-A3F0E66C699B @default.
- Q64612775 P580 Q64612775-20321B37-7C83-4B51-A2EE-0AC3F05A0648 @default.
- Q64612775 P582 Q64612775-CFF69D10-F4C9-4CDC-A953-0BA7D6034D26 @default.
- Q64612775 P6099 Q64612775-701050E7-F8EC-4469-BEBD-A9C4A1919872 @default.
- Q64612775 P6153 Q64612775-2DA8AD5B-A316-441D-86CB-81ADE7E44F82 @default.
- Q64612775 P6153 Q64612775-5A3FF19F-3C9A-45D9-AEA3-1CC08353F4F3 @default.
- Q64612775 P6153 Q64612775-8C738B57-8505-4342-8911-571DBA787148 @default.
- Q64612775 P6153 Q64612775-B342AB53-E2F0-4C34-A90E-16859051E870 @default.
- Q64612775 P8363 Q64612775-631CB68A-982D-4324-8F73-F292A06080DD @default.
- Q64612775 P1132 "+88" @default.
- Q64612775 P1476 "A Phase 2 Clinical Trial Assessing the Correlation of Early Changes in Standardized Uptake Value (SUV) on Positron Emission Tomography (PET) With Pathological Complete Response (pCR) to Pertuzumab and Trastuzumab in Patients With Primary Operable HER2-Positive Breast Cancer" @default.
- Q64612775 P17 Q30 @default.
- Q64612775 P2899 "+18" @default.
- Q64612775 P3098 "NCT01937117" @default.
- Q64612775 P31 Q30612 @default.
- Q64612775 P4844 Q1998021 @default.
- Q64612775 P580 "2014-01-30T00:00:00Z" @default.
- Q64612775 P582 "2018-03-20T00:00:00Z" @default.
- Q64612775 P6099 Q42824440 @default.
- Q64612775 P6153 Q1130172 @default.
- Q64612775 P6153 Q2892284 @default.
- Q64612775 P6153 Q29052 @default.
- Q64612775 P6153 Q7896459 @default.
- Q64612775 P8363 Q78089383 @default.